Bio Protocol announces the approval of the BIOPSY-22 proposal, whereby the core team's $BIO-year Cliff unlock (originally scheduled for 5/28/2025) will be released linearly for six months starting November 14 this year. This move aims to synchronize the token release with the development of the ecosystem, reduce the initial market volatility, and demonstrate the team's commitment and responsible attitude towards the long-term development of the project. (Synopsis: Bio Protocol Launches V1 Upgrade!) Take the DeSci wave to make up for the shortfall in traditional scientific research funding) (Background supplement: BIO listed Binance market value exceeded 2.4 billion magnesium, the first batch to enter the market to earn 57 times! What is the potential of the DeSci field? This article is widely compiled, written and provided by Bio Protocol, and does not represent the position of the region and is not investment advice, purchase or sale advice. For details, please refer to the liability warning at the end of the article. June 2, 2025 — Bio Protocol, a well-known decentralized science (DeSci) project focused on early-stage biotechnology R&D, officially announced on May 28 on the X platform (formerly Twitter) that the Bio Protocol community recently voted unanimously to approve the BIOPSY-22 governance proposal. The proposal extends the 1-year one-time unlock (also known as Cliff Unlock) originally scheduled for May 28, 2025 by 6 months. This part of the token will be gradually unlocked in a linear manner over 6 months from November 14, 2025 (November 14, 2025 ~ May 14, 2026). Core Team's 1-Year $BIO Cliff Stays Locked BIOPSY-22 was unanimously approved Core Team's 1-Year Cliff, originally set to unlock on May 28 2025, will now unlock linearly starting Nov 15, 2025 Aimed at keeping the community focused on shipping, adoption and ecosystem… pic.twitter.com/SGf5u8HxMx — Bio Protocol (@BioProtocol) May 27, 2025 BIOPSY-22 proposal unanimously approved by the community, demonstrating commitment to long-term ecological development According to the proposal, this change is intended to allow earlier versions of the protocol to be promoted while they are still in circulation. Keep the community focused on delivery, adoption, and the long-term growth of the ecosystem, and enable teams to: Reduce circulating supply and minimize volatility before value catalysts materialize during the six-month period when Bio Launchpad is still under construction and revenue-generating features are about to go live. Align unlocks with clear product milestones so as not to diminish the "skin-in-the-game" signal that long-time supporters expect from core contributors. Reduce short-term volatility so it doesn't distract the community from product launches, adoption, and ecosystem growth Relevant core team members affected by this change have been investigated and have agreed to the proposal. Over 700 million $BIO team Cliff unlock changed to linear unlock The original token vesting schedule shows that the tokens held by the core team (about 703.84 million $BIO, accounting for 21.2% of the total supply of 3.32 billion) follow a six-year vesting plan and have a one-time unlock (Cliff Unlock) at the end of the first year. Under the original plan, about 117.3 million $BIO (1/6 team share) will be unlocked once on May 28, 2025, and the remaining 5/6 will be unlocked linearly over the next 5 years (about 117.3 M $BIO per year). The core changes in the BIOPSY-22 proposal are as follows: Deferred and adjusted the Cliff unlock section: The approximately 117.3 million $BIO originally scheduled to be unlocked at one time on May 28, 2025 will instead be unlocked for a six-month period of irreversible continuous linear unlocking from November 14, 2025 to May 14, 2026. Remain the same: The "Cliff Expiry" for the one-year expiry is still May 28, 2025, only tokens will remain locked until the linear unlock begins on November 14, 2025. Among the core team tokens, the tokens that were originally attributed to the main linear unlock (i.e. 5/6 part) will continue to be linearly unlocked from May 28, 2025 to May 28, 2030 according to the original schedule. Governance Significance and Future Prospects: Strengthening Commitment and Ecological Co-prosperity This proposal emphasizes that there will be no dilution of the total number of tokens, but only an adjustment of the release rhythm, which will help maintain market stability and make the incentive mechanism between builders and token holders more coordinated. At the same time, it also sets a precedent for the Bio Protocol governance mechanism to be able to flexibly adjust the token economy model according to market conditions while respecting previous commitments. It is worth noting that the advisor token distribution mentioned in the previous proposal has been removed from the scope of this BIOPSY-22 discussion. Tokens allocated by Molecule AG to Team and Employee Stock Ownership Plan (ESOP) holders will be executed in accordance with Molecule AG's Board of Directors resolution and may be published here for $BIO token holders in the future. In summary, adjusting the one-time unlocking portion of the core team's one-year maturity to a six-month linear release starting November 14, 2025 will better align token unlocking with ecosystem growth milestones, mitigate potential supply shocks, and highlight the team's commitment to responsible management of the $BIO. About Bio Protocol The Bio Protocol is a new financial layer for early-stage biotechnology R&D designed to accelerate the commercialization of breakthrough research. It enables the global community, patients, researchers, and cryptocurrency users to fund and co-own biotech innovations from day one. The agreement is supported by YZi Labs ( formerly Binance Labs), Northpond Ventures and 1kx, and has generated more than $50 million in research funding worldwide. __ Disclaimer: The content of this article is a publicity manuscript provided by the contributor, and the contributor has no relationship with the moving area, and this article does not represent the position of the moving area. This article is not intended to provide any investment, asset advice or legal advice and should not be construed as an offer to buy, sell or hold assets. Any services, programs or tools, etc. mentioned in the content of the publicity manuscript are for reference only, and the final actual content or rules are subject to the announcement or explanation of the contributor,...
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
Bio Core Team Token Unlock Adjustment: BIOPSY-22 Proposal Passed, Demonstrating Long-Term Development Commitment
Bio Protocol announces the approval of the BIOPSY-22 proposal, whereby the core team's $BIO-year Cliff unlock (originally scheduled for 5/28/2025) will be released linearly for six months starting November 14 this year. This move aims to synchronize the token release with the development of the ecosystem, reduce the initial market volatility, and demonstrate the team's commitment and responsible attitude towards the long-term development of the project. (Synopsis: Bio Protocol Launches V1 Upgrade!) Take the DeSci wave to make up for the shortfall in traditional scientific research funding) (Background supplement: BIO listed Binance market value exceeded 2.4 billion magnesium, the first batch to enter the market to earn 57 times! What is the potential of the DeSci field? This article is widely compiled, written and provided by Bio Protocol, and does not represent the position of the region and is not investment advice, purchase or sale advice. For details, please refer to the liability warning at the end of the article. June 2, 2025 — Bio Protocol, a well-known decentralized science (DeSci) project focused on early-stage biotechnology R&D, officially announced on May 28 on the X platform (formerly Twitter) that the Bio Protocol community recently voted unanimously to approve the BIOPSY-22 governance proposal. The proposal extends the 1-year one-time unlock (also known as Cliff Unlock) originally scheduled for May 28, 2025 by 6 months. This part of the token will be gradually unlocked in a linear manner over 6 months from November 14, 2025 (November 14, 2025 ~ May 14, 2026). Core Team's 1-Year $BIO Cliff Stays Locked BIOPSY-22 was unanimously approved Core Team's 1-Year Cliff, originally set to unlock on May 28 2025, will now unlock linearly starting Nov 15, 2025 Aimed at keeping the community focused on shipping, adoption and ecosystem… pic.twitter.com/SGf5u8HxMx — Bio Protocol (@BioProtocol) May 27, 2025 BIOPSY-22 proposal unanimously approved by the community, demonstrating commitment to long-term ecological development According to the proposal, this change is intended to allow earlier versions of the protocol to be promoted while they are still in circulation. Keep the community focused on delivery, adoption, and the long-term growth of the ecosystem, and enable teams to: Reduce circulating supply and minimize volatility before value catalysts materialize during the six-month period when Bio Launchpad is still under construction and revenue-generating features are about to go live. Align unlocks with clear product milestones so as not to diminish the "skin-in-the-game" signal that long-time supporters expect from core contributors. Reduce short-term volatility so it doesn't distract the community from product launches, adoption, and ecosystem growth Relevant core team members affected by this change have been investigated and have agreed to the proposal. Over 700 million $BIO team Cliff unlock changed to linear unlock The original token vesting schedule shows that the tokens held by the core team (about 703.84 million $BIO, accounting for 21.2% of the total supply of 3.32 billion) follow a six-year vesting plan and have a one-time unlock (Cliff Unlock) at the end of the first year. Under the original plan, about 117.3 million $BIO (1/6 team share) will be unlocked once on May 28, 2025, and the remaining 5/6 will be unlocked linearly over the next 5 years (about 117.3 M $BIO per year). The core changes in the BIOPSY-22 proposal are as follows: Deferred and adjusted the Cliff unlock section: The approximately 117.3 million $BIO originally scheduled to be unlocked at one time on May 28, 2025 will instead be unlocked for a six-month period of irreversible continuous linear unlocking from November 14, 2025 to May 14, 2026. Remain the same: The "Cliff Expiry" for the one-year expiry is still May 28, 2025, only tokens will remain locked until the linear unlock begins on November 14, 2025. Among the core team tokens, the tokens that were originally attributed to the main linear unlock (i.e. 5/6 part) will continue to be linearly unlocked from May 28, 2025 to May 28, 2030 according to the original schedule. Governance Significance and Future Prospects: Strengthening Commitment and Ecological Co-prosperity This proposal emphasizes that there will be no dilution of the total number of tokens, but only an adjustment of the release rhythm, which will help maintain market stability and make the incentive mechanism between builders and token holders more coordinated. At the same time, it also sets a precedent for the Bio Protocol governance mechanism to be able to flexibly adjust the token economy model according to market conditions while respecting previous commitments. It is worth noting that the advisor token distribution mentioned in the previous proposal has been removed from the scope of this BIOPSY-22 discussion. Tokens allocated by Molecule AG to Team and Employee Stock Ownership Plan (ESOP) holders will be executed in accordance with Molecule AG's Board of Directors resolution and may be published here for $BIO token holders in the future. In summary, adjusting the one-time unlocking portion of the core team's one-year maturity to a six-month linear release starting November 14, 2025 will better align token unlocking with ecosystem growth milestones, mitigate potential supply shocks, and highlight the team's commitment to responsible management of the $BIO. About Bio Protocol The Bio Protocol is a new financial layer for early-stage biotechnology R&D designed to accelerate the commercialization of breakthrough research. It enables the global community, patients, researchers, and cryptocurrency users to fund and co-own biotech innovations from day one. The agreement is supported by YZi Labs ( formerly Binance Labs), Northpond Ventures and 1kx, and has generated more than $50 million in research funding worldwide. __ Disclaimer: The content of this article is a publicity manuscript provided by the contributor, and the contributor has no relationship with the moving area, and this article does not represent the position of the moving area. This article is not intended to provide any investment, asset advice or legal advice and should not be construed as an offer to buy, sell or hold assets. Any services, programs or tools, etc. mentioned in the content of the publicity manuscript are for reference only, and the final actual content or rules are subject to the announcement or explanation of the contributor,...